Showing results (91-100 of 117) with videos related to
Sort By:
Pageof 12
Cardiologia (Rome, Italy)|January 1, 1995
[Idiopathic atrial fibrillation: clinical-instrumental characterization and thromboembolic risk]G Boriani, A Capucci, V Bruni, et al.Cardiovascular Drugs and Therapy|February 1, 1990
Minimal effective concentration values of propafenone and 5-hydroxy-propafenone in acute and chronic therapyA Capucci, G Boriani, B Marchesini, et al.Circulation|August 2, 2001
Peripheral chemoreceptor hypersensitivity: an ominous sign in patients with chronic heart failureP Ponikowski, T P Chua, S D Anker, et al.Pacing and Clinical Electrophysiology : PACE|January 5, 2001
Atrial overdriving is beneficial in patients with atrial arrhythmias: first results of the PROVE StudyR C Funck, R Adamec, L Lurje, et al.European Heart Journal|September 5, 2002
Efficacy of a dual chamber defibrillator with atrial antitachycardia functions in treating spontaneous atrial tachyarrhythmias in patients with life-threatening ventricular tachyarrhythmiasR Ricci, C Pignalberi, M Disertori, et al.Cardiologia (Rome, Italy)|June 1, 1995
[Transvenous cardioverter-defibrillators: clinical experience at implantation and follow-up]G Boriani, L Frabetti, A Capucci, et al.Annals of Internal Medicine|April 15, 1997
Oral propafenone to convert recent-onset atrial fibrillation in patients with and without underlying heart disease. A randomized, controlled trialG Boriani, M Biffi, A Capucci, et al.International Journal of Cardiology|January 3, 1997
Conversion of recent onset atrial fibrillation to sinus rhythm using a single oral loading dose of propafenone: comparison of two regimensG L Botto, A Capucci, W Bonini, et al.The American Journal of Cardiology|September 11, 1998
Clinical reliability of single-lead VDD pacing from evaluation of P-wave sensing under dynamic conditionsG Boriani, M Biffi, A Bandini, et al.The Journal of Antimicrobial Chemotherapy|January 26, 2008
Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant Escherichia coli among patients with haematological malignancies: results of a prospective study on 823 patients at a single institutionC Cattaneo, G Quaresmini, S Casari, et al.Pageof 12